Dyadic International Inc (DYAI) - Total Assets
Based on the latest financial reports, Dyadic International Inc (DYAI) holds total assets worth $11.67 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Dyadic International Inc - Total Assets Trend (2003–2024)
This chart illustrates how Dyadic International Inc's total assets have evolved over time, based on quarterly financial data. Also see Dyadic International Inc stock valuation for the company's overall valuation and market capitalisation.
Dyadic International Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Dyadic International Inc's total assets of $11.67 Million consist of 99.0% current assets and 1.0% non-current assets. Review DYAI liabilities breakdown to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 65.5% |
| Accounts Receivable | $237.03K | 2.4% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2003–2024)
This chart illustrates how Dyadic International Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See latest Dyadic International Inc stock price today for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Dyadic International Inc's current assets represent 99.0% of total assets in 2024, a decrease from 100.0% in 2003.
- Cash Position: Cash and equivalents constituted 65.5% of total assets in 2024, down from 76.2% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 7207.0% in 2003.
- Asset Diversification: The largest asset category is accounts receivable at 2.4% of total assets.
Dyadic International Inc Competitors by Total Assets
Key competitors of Dyadic International Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ALK-Abelló A/S
CO:ALK-B
|
Denmark | Dkr9.17 Billion |
|
Mirum Pharmaceuticals Inc
NASDAQ:MIRM
|
USA | $890.92 Million |
|
Xiamen Amoytop Biotech Co Ltd
SHG:688278
|
China | CN¥3.21 Billion |
|
BB Biotech AG
SW:BION
|
Switzerland | CHF3.09 Billion |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $608.39 Million |
|
Nanobiotix
NASDAQ:NBTX
|
USA | $67.76 Million |
|
Inhibrx Biosciences, Inc.
NASDAQ:INBX
|
USA | $183.97 Million |
|
Wuhan Keqian Biology Co Ltd
SHG:688526
|
China | CN¥4.75 Billion |
Dyadic International Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.85 | 5.15 | 18.32 |
| Quick Ratio | 2.85 | 5.15 | 18.32 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $7.49 Million | $8.61 Million | $28.16 Million |
Dyadic International Inc - Advanced Valuation Insights
This section examines the relationship between Dyadic International Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.52 |
| Latest Market Cap to Assets Ratio | 1.54 |
| Asset Growth Rate (YoY) | 20.8% |
| Total Assets | $9.93 Million |
| Market Capitalization | $15.33 Million USD |
Valuation Analysis
Above Book Valuation: The market values Dyadic International Inc's assets above their book value (1.54x), reflecting positive investor sentiment about the company's future prospects.
Rapid Asset Growth: Dyadic International Inc's assets grew by 20.8% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Dyadic International Inc (2003–2024)
The table below shows the annual total assets of Dyadic International Inc from 2003 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $9.93 Million | +20.82% |
| 2023-12-31 | $8.22 Million | -40.06% |
| 2022-12-31 | $13.71 Million | -35.62% |
| 2021-12-31 | $21.30 Million | -29.17% |
| 2020-12-31 | $30.07 Million | -19.71% |
| 2019-12-31 | $37.45 Million | -13.51% |
| 2018-12-31 | $43.30 Million | -14.67% |
| 2017-12-31 | $50.74 Million | -13.55% |
| 2016-12-31 | $58.70 Million | -23.43% |
| 2015-12-31 | $76.67 Million | +798.23% |
| 2014-12-31 | $8.54 Million | -42.87% |
| 2013-12-31 | $14.94 Million | +15.99% |
| 2012-12-31 | $12.88 Million | +25.06% |
| 2011-12-31 | $10.30 Million | +0.68% |
| 2010-12-31 | $10.23 Million | -28.76% |
| 2009-12-31 | $14.36 Million | +37.68% |
| 2008-12-31 | $10.43 Million | -60.02% |
| 2007-12-31 | $26.09 Million | -42.20% |
| 2006-12-31 | $45.14 Million | +90.03% |
| 2005-12-31 | $23.75 Million | -27.41% |
| 2004-12-31 | $32.72 Million | +198422.27% |
| 2003-12-31 | $16.48K | -- |
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and la… Read more